If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

Diversifying healthcare financing is essential as Vietnam's system evolves, AstraZeneca Vietnam's chairman tells VIR.

Periodontitis remains a major global health challenge, but better outcomes depend on consensus in diagnosis, collaboration ...

Recently, I've been in a Lyme state of mind. For one thing, as spring turns to summer, I can't help remembering the ...

Learning to identify bug bites and stings will help you get the right treatment. We break down the bites of mosquitos, fleas, spiders, and more.

Melatonin, the sleep aid tucked into many medicine cabinets, may also have a place in chronic pain care. A new analysis from ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

A new international expert consensus statement published in The Lancet Respiratory Medicine provides guidance for doctors on ...

Experts told Newsweek there are several symptoms people often dismiss without realizing what they could be pointing to.

Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...

GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the ...